Clinical Trials

Showing trials with last updates posted in 2024.

NCT03967158 | ACTIVE_NOT_RECRUITING
2000 Participants

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2019-12-23
Completion: 2024-08-27
Conditions
Coronary Artery Disease Coronary Disease
Interventions
DEVICE
No Results Yet
NCT03951194 | RECRUITING | PHASE2/PHASE3
100 Participants

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-06-13
Completion: 2025-01-30
Conditions
Infertility, Female Perimenopausal Disorder Menstrual Cycle Abnormal
Interventions
BIOLOGICAL OTHER
No Results Yet
NCT03949387 | COMPLETED | NA
10 Participants

Functional Electrical Stimulation Cycling for Managing Mobility Disability in People with Multiple Sclerosis

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-10-16
Completion: 2024-10-28
Conditions
Multiple Sclerosis
Interventions
OTHER
No Results Yet
NCT03930199 | ACTIVE_NOT_RECRUITING | NA
66 Participants

Personalized Mobility Interventions Using Smart Sensor Resources for Lower-Limb Prosthesis Users

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2020-05-01
Completion: 2025-12-31
Conditions
Amputation
Interventions
OTHER
No Results Yet
NCT03885518 | COMPLETED | NA
51 Participants

Painted Playgrounds: Aim 2: Assessments

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-12-15
Completion: 2019-06-30
Conditions
Childhood Obesity
Interventions
OTHER
NCT03837821 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
20 Participants

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-02-05
Completion: 2024-07-02
Conditions
Bladder Cancer
Interventions
DRUG
No Results Yet
NCT03804905 | NOT_YET_RECRUITING | NA
144 Participants

STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2026-01-01
Completion: 2026-12-31
Conditions
Type 2 Diabetes Mellitus Medication Adherence Medication Compliance Medication Nonadherence
Interventions
OTHER
No Results Yet
NCT03797716 | COMPLETED | NA
596 Participants

Paediatric Peri-operative Anxiety: Does the Little Journey App Help?

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-09-09
Completion: 2024-03-31
Conditions
Anxiety Acute Anxiety Fear Peri-operative Psychological Distress Surgery Children, Only
Interventions
DEVICE
No Results Yet
NCT03788369 | RECRUITING
200 Participants

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2019-04-05
Completion: 2030-06-30
Conditions
Percutaneous Coronary Revascularization Coronary Stenosis Coronary Artery Disease Progression Coronary Artery Bypass Grafting
Interventions
PROCEDURE
No Results Yet
NCT03710603 | ACTIVE_NOT_RECRUITING | PHASE3
709 Participants

Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-12-14
Completion: 2023-08-01
Conditions
Multiple Myeloma
Interventions
DRUG
NCT03650712 | COMPLETED | NA
317 Participants

EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-07-01
Completion: 2023-08-31
Conditions
Cystic Fibrosis-related Diabetes
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT03640858 | COMPLETED | NA
82 Participants

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-05-08
Completion: 2023-04-30
Conditions
End Stage Renal Disease
Interventions
DEVICE
No Results Yet
NCT03639883 | COMPLETED | PHASE1/PHASE2
16 Participants

A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-11-05
Completion: 2019-12-04
Conditions
Scar Incision Abdominal Wound (Morphologic Abnormality)
Interventions
DRUG
No Results Yet
NCT03603600 | COMPLETED | NA
501 Participants

Evaluate the Safety and Effectiveness of the enVistaยฎ One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-05-31
Completion: 2023-05-04
Conditions
Cataract
Interventions
DEVICE
NCT03588481 | RECRUITING
1000 Participants

IRIS- DESyne X2 in the IRIS-DES Registry

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2018-11-28
Completion: 2026-12-31
Conditions
Coronary Stenosis Coronary Occlusion Coronary Disease
Interventions
DEVICE
No Results Yet
NCT03587272 | RECRUITING | PHASE2
100 Participants

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-04-17
Completion: 2030-11-30
Conditions
Sickle Cell Disease
Interventions
DRUG
No Results Yet
NCT03582033 | TERMINATED | PHASE1
83 Participants

A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-11-01
Completion: 2023-11-09
Conditions
Multiple Myeloma
Interventions
DRUG
NCT03576989 | COMPLETED | NA
296 Participants

Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2019-04-15
Completion: 2024-12-18
Conditions
Chronic Venous Leg Ulcers
Interventions
DIETARY_SUPPLEMENT OTHER
No Results Yet
NCT03575013 | ACTIVE_NOT_RECRUITING | PHASE1
21 Participants

A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-10-29
Completion: 2021-12-15
Conditions
Urothelial Carcinoma
Interventions
DRUG
No Results Yet
NCT03574727 | COMPLETED
35 Participants

Abdominal Cutaneous Nerve Entrapment Syndrome

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2017-09-15
Completion: 2018-09-19
Conditions
Abdominal Pain Abdominal Cutaneous Nerve Entrapment Syndrome
Interventions
PROCEDURE
No Results Yet
NCT03485729 | TERMINATED | PHASE2
27 Participants

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-03-21
Completion: 2023-01-19
Conditions
Endometrial Cancer Recurrent
Interventions
DRUG
NCT03480061 | ACTIVE_NOT_RECRUITING | PHASE4
90 Participants

Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-08-09
Completion: 2026-07-31
Conditions
Delirium Postoperative Cognitive Dysfunction Dexmedetomidine Cognitive Impairment Depression
Interventions
DRUG
No Results Yet
NCT03453567 | ACTIVE_NOT_RECRUITING
900 Participants

Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2018-05-10
Completion: 2030-06-15
Conditions
Aortic Valve Disease Aortic Valve Stenosis
Interventions
PROCEDURE
No Results Yet
NCT03437486 | RECRUITING
750 Participants

Mechanisms of Familial Pulmonary Fibrosis

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2009-01-01
Completion: 2030-01-30
Conditions
Familial Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis Familial Interstitial Pneumonia
No Results Yet
NCT03394079 | ACTIVE_NOT_RECRUITING | NA
2008 Participants

Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-04-12
Completion: 2023-02-17
Conditions
Coronary Vessels
Interventions
PROCEDURE
No Results Yet
NCT03391466 | COMPLETED | PHASE3
359 Participants

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-01-25
Completion: 2021-03-18
Conditions
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Interventions
BIOLOGICAL DRUG
NCT03350516 | COMPLETED | PHASE3
22000 Participants

Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-11-30
Completion: 2022-11-03
Conditions
Pregnancy Related
Interventions
DIETARY_SUPPLEMENT
No Results Yet
NCT03332940 | TERMINATED | PHASE1
6 Participants

Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-12-06
Completion: 2019-03-10
Conditions
Nonalcoholic Steatohepatitis NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG
No Results Yet
NCT03328702 | COMPLETED | NA
4 Participants

CPAP to Improve Swallow Function Post Total Laryngectomy

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2016-06-27
Completion: 2022-11-08
Conditions
Oropharyngeal Dysphagia Laryngectomy; Status
Interventions
DEVICE
NCT03298178 | RECRUITING
6000 Participants

ASAN Medical Center Aortic Valve Replacement Registry

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2017-12-01
Completion: 2030-12-15
Conditions
Aortic Valve Stenosis
Interventions
PROCEDURE
No Results Yet
NCT03278379 | COMPLETED | PHASE2
17 Participants

Avelumab in G2-3 NET

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-11-15
Completion: 2021-07-26
Conditions
Neuroendocrine Tumors
Interventions
DRUG
No Results Yet
NCT03215706 | COMPLETED | PHASE3
719 Participants

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-08-24
Completion: 2019-08-16
Conditions
Non-Small Cell Lung Cancer
Interventions
BIOLOGICAL DRUG
NCT03194685 | COMPLETED | PHASE1
97 Participants

Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-05-05
Completion: 2021-07-31
Conditions
AML, Adult
Interventions
DRUG
No Results Yet
NCT03180996 | ACTIVE_NOT_RECRUITING
160 Participants

Global Fenestrated Anaconda Clinical STudy

Study Type: OBSERVATIONAL
Last Updated: 2024-12-24
Start Date: 2017-09-11
Completion: 2022-03-31
Conditions
Abdominal Aortic Aneurysm
Interventions
DEVICE
No Results Yet
NCT03172624 | COMPLETED | PHASE2
64 Participants

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-05-26
Completion: 2024-12-18
Conditions
Salivary Gland Cancer
Interventions
DRUG
No Results Yet
NCT03150914 | ACTIVE_NOT_RECRUITING | PHASE3
60 Participants

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2018-01-01
Completion: 2025-06-30
Conditions
LAM Lymphangioleiomyomatosis
Interventions
DRUG
No Results Yet
NCT03099499 | TERMINATED | PHASE2
19 Participants

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-06-08
Completion: 2020-09-09
Conditions
Endometrial Cancer
Interventions
DRUG
No Results Yet
NCT03092453 | COMPLETED | PHASE1
5 Participants

Dendritic Cell Vaccination in Patients With Advanced Melanoma

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-05-01
Completion: 2023-03-31
Conditions
Melanoma
Interventions
BIOLOGICAL DRUG
NCT03084536 | COMPLETED | PHASE2
134 Participants

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-06-07
Completion: 2021-02-25
Conditions
Breast Cancer Breast Cancer Female Cancer of Breast
Interventions
DRUG
NCT03052608 | ACTIVE_NOT_RECRUITING | PHASE3
296 Participants

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

Study Type: INTERVENTIONAL
Last Updated: 2024-12-24
Start Date: 2017-04-27
Completion: 2020-03-20
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 68888 trials